Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Dristhi Ragoonanan(The University of Texas MD Anderson Cancer Center), Kris M. Mahadeo(Duke University), Keri Schadler(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Leslie Lehmann(Harvard University), Natalie Dailey Garnes(National Institutes of Health), Priti Tewari(The University of Texas MD Anderson Cancer Center), Sangeeta Hingorani(University of Washington), Matteo Di Nardo(Bambino Gesù Children's Hospital), Ali Ahmad(The University of Texas MD Anderson Cancer Center), Jonathan Gill(Albert Einstein College of Medicine), Sajad Khazal(The University of Texas MD Anderson Cancer Center), Branko Cuglievan(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Alison Gulbis(The University of Texas MD Anderson Cancer Center), Rita D. Swinford(The University of Texas Health Science Center at Houston), Maria E. Mireles(The University of Texas MD Anderson Cancer Center), Sung Won Choi(University of Michigan), Basirat Shoberu(Albert Einstein College of Medicine), David McCall(The University of Texas MD Anderson Cancer Center), Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Hisham Abdel‐Azim(University of Southern California), Selim Corbacioglu(Unknown), Jeffery J. Auletta(NHS Blood and Transplant), Courtney M. Rowan(Children's Hospital of Wisconsin), Francesco Paolo Tambaro(The University of Texas MD Anderson Cancer Center), Julie C. Fitzgerald(Children's Hospital of Philadelphia), William G. Wierda(University of Maryland, Baltimore), Neena Kapoor(University of Southern California), Cristina Gutiérrez(The University of Texas MD Anderson Cancer Center), Marie E. Steiner, Paul L. Martin(Duke University), Fiorela N. Hernandez Tejada(The University of Texas MD Anderson Cancer Center), Joseph Angelo(Baylor College of Medicine), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Jennifer McArthur(St. Jude Children's Research Hospital), Linda Chi(The University of Texas MD Anderson Cancer Center), Rajinder Bajwa(Nationwide Children's Hospital), Demetrios Petropoulos(The University of Texas MD Anderson Cancer Center), Jeffrey D. Miller(The University of Texas MD Anderson Cancer Center)
Cited by 58
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
|Proceedings of the National Academy of Sciences|2002|963
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902